FDA 483 - Omega & Delta Co., Inc. - October 23, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Omega & Delta Co., Inc. in Carolina, PR, a drug manufacturer, revealed significant deficiencies across its quality control unit and manufacturing operations. The firm lacked a functional quality control unit, failed to follow good documentation practices, and did not perform required annual product reviews or maintain proper sample storage. Additionally, the inspection noted issues with water system validation and a failure to adhere to its written stability testing program, with several observations being repeats from a previous inspection.
ID · 52499281-7aa0-48b8-aab2-b74a7c1cae68